Sheila Vasan in Van Nuys, California

Home California Van Nuys

Sheila Vasan has Hematology/oncology as her primary medical specialty. Their primary office is: 15211 Vanowen St in Van Nuys, California.

They're a part of the: Los Angeles Hematology-oncology Medical Group medical group which has around 18 members. You can call their office at 818-782-4104 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, her university is not listed and graduated in 2007 (around 17 years of experience). They are listed as doing telehealth appointments.

Sheila Vasan Office Phone and Directions

Sheila Vasan
Los Angeles Hematology-oncology Medical Group
15211 Vanowen St
Van Nuys, California 91405
818-782-4104

Patient Ratings
Please rate your experience with Sheila Vasan below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 818-782-4104

Enter a starting address:

Healthcare Info for Sheila Vasan

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, her university is not listed
Graduation Year: 2007
The Primary Medical Specialty for Sheila Vasan is listed as: Hematology/oncology
Approximate Years of Experience: 17
PAC (PECOS ID)#: 7214178789
NPI #: 1487846416
NPI Created On: 08/14/2007
NPI Last Updated Listed as: 06/14/2023
Primary Taxonomy Code: 207RH0003X
License Number:
A106086
Listed Gender: Female

Procedures, Services, Charges

Services and Procedures include:

Insertion of needle into vein for collection of blood sample
Complete blood cell count (red cells, white blood cell, platelets), automated test
Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
Infusion of chemotherapy into a vein up to 1 hour
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day
Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a
Injection, dexamethasone sodium phosphate, 1 mg
Injection, diphenhydramine hcl, up to 50 mg
Injection, palonosetron hcl, 25 mcg

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $39

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 799853789

Being Disputed:: No

Product Related: Yes

Drug or Biological: Device

Product Category #1: ONCOLOGY

Name of Drug #1: FOUNDATIONONE

Drug or Biological: Device

Product Category #2: ONCOLOGY

Name Of Drug #2:: FOUNDATIONONE HEME

Drug or Biological #3:: Device

Product Category #3: ONCOLOGY

Name of Drug: FOUNDATIONONE CDX

Drug or Biological: Device

Product Category #4: ONCOLOGY

Name of Drug #4: FOUNDATIONFOCUS

Drug or Biological #4:: Device

Product Category #5: ONCOLOGY

Name of Drug #5: FOUNDATIONONE LIQUID CDX

Payments Total: $29

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781015845

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $25

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781015847

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $27

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781015849

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 796198037

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: VENCLEXTA

Open Associated Drug #1: 0074-0576-22

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 796198039

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: VENCLEXTA

Open Associated Drug #1: 0074-0576-22

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818700729

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: CYRAMZA

Open Associated Drug #1: 0002-7669-01

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: RETEVMO

Associated Drug #2: 0002-2980-60

Payments Total: $27

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818752567

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: CYRAMZA

Open Associated Drug #1: 0002-7669-01

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: RETEVMO

Associated Drug #2: 0002-2980-60

Payments Total: $25

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818752569

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: CYRAMZA

Open Associated Drug #1: 0002-7669-01

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: RETEVMO

Associated Drug #2: 0002-2980-60

Payments Total: $31

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818752571

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: VERZENIO

Open Associated Drug #1: 0002-6216-54

Hematology/oncology Professionals in Van Nuys

1.
Nubar Boghossian MD

15211 Vanowen St
Van-nuys, CA
Los Angeles Hematology-oncology Medical Group

2.
Jotika Thompson MD

15211 Vanowen St
Van-nuys, CA
Los Angeles Hematology-oncology Medical Group

Providers in Los Angeles Hematology-oncology Medical Group

1.Boris Bagdasarian

1505 Wilson Ter
Glendale Ca 91206-4073
Los Angeles Hematology-oncology Medical Group
Hematology/oncology

2.Nubar Boghossian Md

222 W Eulalia St
Glendale Ca 91204-2850
Los Angeles Hematology-oncology Medical Group
Hematology/oncology

3.Nubar Boghossian Md

15211 Vanowen St
Van Nuys Ca 91405-3627
Los Angeles Hematology-oncology Medical Group
Hematology/oncology

4.Weber Chen Md

50 Alessandro Pl
Pasadena Ca 91105-4000
Los Angeles Hematology-oncology Medical Group
Hematology/oncology

5.Shahrooz Eshaghian

2080 Century Park E
Los Angeles Ca 90067-2013
Los Angeles Hematology-oncology Medical Group
Hematology/oncology

6.Rodolfo Gutierrez

433 N 4th St
Montebello Ca 90640-4309
Los Angeles Hematology-oncology Medical Group
Hematology/oncology

View all 18 members of Los Angeles Hematology-oncology Medical Group medical group